Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-011610
Filing Date
2023-04-03
Accepted
2023-04-03 16:31:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A crbp-proxy-notice-2023.htm DEFA14A 13461
2 GRAPHIC img65945893_0.jpg GRAPHIC 74401
3 GRAPHIC img65945893_1.jpg GRAPHIC 48934
  Complete submission text file 0000950170-23-011610.txt   184622
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37348 | Film No.: 23793186
SIC: 2834 Pharmaceutical Preparations